SPC
TFFP

Sigma Planning Corp’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Sigma Planning Corp’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,802
Closed -$50.8K – 1204
2023
Q3 		$50.8K Hold
5,802
– – ﹤0.01% 1159
2023
Q2 		$68.2K Sell
5,802
-406
-7% -$5.83K ﹤0.01% 1163
2023
Q1 		$106K Buy
6,208
+2,172
+54% +$47.1K ﹤0.01% 1233
2022
Q4 		$106K Buy
4,036
+960
+31% +$45.5K ﹤0.01% 1195
2022
Q3 		$312K Buy
3,076
+12
+0.4% +$1.62K 0.01% 929
2022
Q2 		$433K Buy
3,064
+20
+0.7% +$2.79K 0.02% 814
2022
Q1 		$480K Sell
3,044
-16
-0.5% -$2.58K 0.01% 859
2021
Q4 		$679K Buy
3,060
+24
+0.8% +$4.64K 0.02% 706
2021
Q3 		$586K Buy
3,036
+158
+5% +$33.5K 0.02% 747
2021
Q2 		$691K Buy
2,878
+162
+6% +$44.4K 0.02% 693
2021
Q1 		$921K Sell
2,716
-760
-22% -$309K 0.03% 534
2020
Q4 		$1.24M Sell
3,476
-8
-0.2% -$3.08K 0.04% 385
2020
Q3 		$1.61M Sell
3,484
-282
-7% -$79.6K 0.06% 284
2020
Q2 		$542K Buy
3,766
+184
+5% +$23.3K 0.02% 563
2020
Q1 		$344K Buy
3,582
+3,162
+753% +$376K 0.02% 596
2019
Q4 		$56K Buy
+420
New +$53.9K ﹤0.01% 1031

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sigma Planning Corp's TFFP Position: Q4 2023 in Review

Sigma Planning Corp sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 5,802 shares — an estimated $50.8K sold.

Sigma Planning Corp first reported a position in TFFP in Q4 2019 and held it in 16 quarters. The position peaked at $1.61M in Q3 2020. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

  • Sigma Planning Corp reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Sigma Planning Corp sold 5,802 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $50.8K.
  • Sigma Planning Corp first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 16 quarters.
  • Sigma Planning Corp's TFF Pharmaceuticals, Inc. Common Stock position peaked at $1.61M in Q3 2020.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Sigma Planning Corp's 13F filing for Q4 2023, filed 1 Feb 2024.